Literature DB >> 30721406

Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation.

Hiroaki Sekiya1, Hisatomo Kowa2,3, Hinako Koga1, Mariko Takata1, Wataru Satake1, Naonobu Futamura4, Itaru Funakawa4, Kenji Jinnai4, Motonori Takahashi5, Takeshi Kondo5, Yasuhiro Ueno5, Motoi Kanagawa1, Kazuhiro Kobayashi1, Tatsushi Toda6,7.   

Abstract

Multiple system atrophy (MSA) is a fatal adult-onset neurodegenerative disease that is characterized by varying degrees of cerebellar dysfunction and Parkinsonism. The neuropathological hallmark of MSA is alpha-synuclein (AS)-positive glial cytoplasmic inclusions (GCIs). Although severe neuronal loss (NL) is also observed in MSA, neuronal inclusions (NIs) are rare compared to GCIs, such that the pathological mechanism of NL in MSA is unclear. GCIs and NIs are late-stage pathology features relative to AS oligomers and may not represent early pathological changes in MSA. To reveal the early pathology of MSA, it is necessary to examine the early aggregation of AS, i.e., AS oligomers. Here, we adopted a proximity ligation assay (PLA) to examine the distribution of AS oligomers in brain tissue samples from patients with MSA and other diseases. Surprisingly, MSA brains showed a widespread distribution and abundant accumulation of oligomeric AS in neurons as well as oligodendrocytes of the neocortex. In several regions, oligomeric AS signal intensity was higher in cases with MSA than in cases with Parkinson's disease. In contrast to previous studies, AS-PLA revealed abundant AS oligomer accumulation in Purkinje cells in MSA brains, identifying oligomeric AS accumulation as a possible cause of Purkinje cell loss. This wide distribution of AS oligomers in MSA brain neurons has not been described previously and indicates a pathological mechanism of NL in MSA.

Entities:  

Keywords:  Alpha-synuclein; Multiple system atrophy; Oligomer; Pathogenesis

Mesh:

Substances:

Year:  2019        PMID: 30721406     DOI: 10.1007/s00401-019-01961-w

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

Review 1.  Can infections trigger alpha-synucleinopathies?

Authors:  Christopher T Tulisiak; Gabriela Mercado; Wouter Peelaerts; Lena Brundin; Patrik Brundin
Journal:  Prog Mol Biol Transl Sci       Date:  2019-07-03       Impact factor: 3.622

Review 2.  Reverse engineering Lewy bodies: how far have we come and how far can we go?

Authors:  Mohamed Bilal Fares; Somanath Jagannath; Hilal A Lashuel
Journal:  Nat Rev Neurosci       Date:  2021-01-11       Impact factor: 34.870

Review 3.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

4.  Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.

Authors:  Koichi Wakabayashi; Yasuo Miki; Kunikazu Tanji; Fumiaki Mori
Journal:  Cerebellum       Date:  2022-04-26       Impact factor: 3.847

Review 5.  Multiple system atrophy.

Authors:  Werner Poewe; Iva Stankovic; Glenda Halliday; Wassilios G Meissner; Gregor K Wenning; Maria Teresa Pellecchia; Klaus Seppi; Jose-Alberto Palma; Horacio Kaufmann
Journal:  Nat Rev Dis Primers       Date:  2022-08-25       Impact factor: 65.038

6.  Electrophilic and Drug-Induced Stimulation of NOTCH3 N-terminal Fragment Oligomerization in Cerebrovascular Pathology.

Authors:  K Z Young; N M P Cartee; S J Lee; S G Keep; M I Ivanova; Michael M Wang
Journal:  Transl Stroke Res       Date:  2021-05-03       Impact factor: 6.829

7.  Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.

Authors:  Nelson Ferreira; Hjalte Gram; Zachary A Sorrentino; Emil Gregersen; Sissel Ida Schmidt; Lasse Reimer; Cristine Betzer; Clara Perez-Gozalbo; Marjo Beltoja; Madhu Nagaraj; Jie Wang; Jan S Nowak; Mingdong Dong; Katarina Willén; Ersoy Cholak; Kaare Bjerregaard-Andersen; Nicolas Mendez; Prakruti Rabadia; Mohammad Shahnawaz; Claudio Soto; Daniel E Otzen; Ümit Akbey; Morten Meyer; Benoit I Giasson; Marina Romero-Ramos; Poul Henning Jensen
Journal:  Acta Neuropathol       Date:  2021-05-12       Impact factor: 17.088

8.  Stabilization of α-synuclein oligomers using formaldehyde.

Authors:  Harm Ruesink; Lasse Reimer; Emil Gregersen; Arne Moeller; Cristine Betzer; Poul Henning Jensen
Journal:  PLoS One       Date:  2019-10-11       Impact factor: 3.240

9.  Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing.

Authors:  Diego Perez-Rodriguez; Maria Kalyva; Melissa Leija-Salazar; Tammaryn Lashley; Maxime Tarabichi; Viorica Chelban; Steve Gentleman; Lucia Schottlaender; Hannah Franklin; George Vasmatzis; Henry Houlden; Anthony H V Schapira; Thomas T Warner; Janice L Holton; Zane Jaunmuktane; Christos Proukakis
Journal:  Acta Neuropathol Commun       Date:  2019-12-23       Impact factor: 7.801

Review 10.  Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities.

Authors:  Naomi P Visanji; Anthony E Lang; Gabor G Kovacs
Journal:  Transl Neurodegener       Date:  2019-09-04       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.